# US 2012/0255046 A1 · In vivo transduction with a chimeric aav capsid protein

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0255046 A1
- Document ID: US20120255046A1
- Status: Published application
- Kind: A1
- Application number: 13/472,260
- Filed: 2012-05-15
- Published: 2012-10-04
- Earliest claimed: 2006-03-30
- Assignees: The Board of Trustees of the Leland Stanford University
- Inventors: MARK KAY; Dirk Grimm
- Web page: https://patentgrep.com/patent/US20120255046A1

## CPC

- C12N 15/1082: {Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors}
- C07K 14/005: from viruses
- C12N 15/86: Viral vectors
- C12N 2750/14122: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2750/14143: viral genome or elements thereof as genetic vector
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Recombinant adeno-associated viral (AAV) capsid proteins are provided. Methods for generating a library of recombinant adeno-associated viral capsid proteins are also provided.

## Claims

### Claim 1

A transduced animal, comprising: a recombinant AAV particle, wherein the AAV particle comprises a capsid protein having an amino acid sequence selected from the group consisting of (i) sequences having at least 95% sequence identity over the entire length of SEQ ID NO:1, and (ii) SEQ ID NO:1, and a DNA of interest encapsidated in the capsid protein.

### Claim 2 (depends on 1)

The animal of claim 1, wherein the animal is a mammal.

### Claim 3

A cell comprising a DNA of interest, wherein the cell is transduced using a recombinant AAV vector comprising a DNA of interest which is encapsidated in a capsid protein having an amino acid sequence selected from the group of sequences consisting of (i) sequences having at least 95% sequence identity over the entire length of SEQ ID NO:1 and (ii) SEQ ID NO:1.

### Claim 4 (depends on 3)

An animal comprising a cell of claim 3.

### Claim 5 (depends on 3)

A cell line produced from a cell of claim 3.

### Claim 6

An animal comprising a DNA of interest, wherein the DNA of interest is introduced into the animal by a method comprising transducing a cell with a recombinant AAV particle, the recombinant AAV particle comprising a DNA of interest which is encapsidated in a capsid protein having an amino acid sequence selected from the group of sequences consisting of (i) sequences having at least 95% sequence identity over the entire length of SEQ ID NO:1 and (ii) SEQ ID NO:1.

### Claim 7 (depends on 5)

The animal of claim 5, wherein the animal is a mammal.

### Claim 8

A cell comprising a DNA of interest, wherein the cell is produced from a transduced cell, the transduced cell transduced using a recombinant AAV vector comprising a DNA of interest that delivers the DNA of interest into the cell to be transduced, wherein the recombinant AAV vector encapsidates the DNA of interest in a capsid protein having an amino acid sequence selected from the group of sequences consisting of (i) sequences having at least 95% sequence identity over the entire length of SEQ ID NO:1 and (ii) SEQ ID NO:1.
